ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

NCI Plans a Catalog Of Research Tools

April 30, 1999

CHMP Delivers Positive Opinion For Two-Dose HPV Vaccine

February 28, 2014

Hospitals Win Grants For Radiation Oncology Disparity Research.

January 3, 2003

The Cancer Letter Offers FAX Delivery

January 7, 1994